Biotechnology stocks are firms that are active in the sector and publicly traded. Biotechnology companies use applied biology for advancements in current methodologies in a variety of industries. The field uses living organisms and bio-processes in many sectors, such as medicine, engineering, agriculture and technology. Since there is a lot of research and development in this sector, small biotech stocks that can develop a new advancement in technology can become very wealthy firms and the stock price can move up sharply. Biotechnology stocks raise money in the public market to help fund this research.
The best biotech stocks to watch for in May 2015 are businesses that dominate their respective market, command a diverse drug pipeline, and have lots of profits to show for it.Profitability is crucial given that the NASDAQ Biotechnology Index continues to climb higher, gaining 12% in 2015 and adding to the 36% increase in 2014. Biotech. Read More
The main market indices remain in consolidation, with the more speculative averages like the Russell 2000 and NASDAQ Biotechnology Index now experiencing a bit of a price retrenchment. However, biotech stocks are still the place to be if you’re looking for a lot of growth.Among risk-capital sectors of the equity market, biotech. Read More
In searching for the top biotech stocks to watch in 2015, let’s not forget that many on Wall Street are talking about the group’s sky-high valuations. In fact, since the start of 2012, the NASDAQ Biotechnology index has gained 256%. In the same period, the S&P 500 has only mustered a 65% gain.With that in mind, it’s important. Read More
With indecisive stock market action, biotechnology stocks continue to show their speculative strength. It’s a market sector that continues to be very strong, albeit highly speculative.Of course, where there’s growth, there are also higher valuations and many of the large-cap biotechnology and pharmaceutical companies are. Read More
One of the hottest areas of the stock market over the last few years has been one of its most speculative. Biotechnology stocks, as evidenced by the NASDAQ Biotechnology Index, have been on a tear for the last three years.This index was 1,000 at the end of 2011; it was 1,500 by the beginning of 2013; and now, it’s just shy of 3,200 for an all-time. Read More